Issue navigation
Volume 18, Issue 1, January 2016
Editorials
Non-vitamin K oral anticoagulants in ‘valvular’ atrial fibrillation: a call for action
Jan Steffel and Dan Atar
EP Europace, Volume 18, Issue 1, January 2016, Pages 1–3, https://doi.org/10.1093/europace/euv318
Stay cool or in good contact?
Karl H. Kuck and others
EP Europace, Volume 18, Issue 1, January 2016, Pages 4–5, https://doi.org/10.1093/europace/euv226
Review
Non-vitamin K antagonist oral anticoagulants in atrial fibrillation accompanying mitral stenosis: the concept for a trial
Raffaele De Caterina and A. John Camm
EP Europace, Volume 18, Issue 1, January 2016, Pages 6–11, https://doi.org/10.1093/europace/euv288
EHRA/HFA POSITION PAPER
European Heart Rhythm Association/Heart Failure Association joint consensus document on arrhythmias in heart failure, endorsed by the Heart Rhythm Society and the Asia Pacific Heart Rhythm Society
Gregory Y.H. Lip and others
EP Europace, Volume 18, Issue 1, January 2016, Pages 12–36, https://doi.org/10.1093/europace/euv191
EHRA CONSENSUS STATEMENT
A roadmap to improve the quality of atrial fibrillation management: proceedings from the fifth Atrial Fibrillation Network/European Heart Rhythm Association consensus conference
Paulus Kirchhof and others
EP Europace, Volume 18, Issue 1, January 2016, Pages 37–50, https://doi.org/10.1093/europace/euv304
Clinical Research
Atrial fibrillation
Vernakalant-facilitated electrical cardioversion: comparison of intravenous vernakalant and amiodarone for drug-enhanced electrical cardioversion of atrial fibrillation after failed electrical cardioversion
Andreas Müssigbrodt and others
EP Europace, Volume 18, Issue 1, January 2016, Pages 51–56, https://doi.org/10.1093/europace/euv194
CASE EXPRESS REPORTS
Slow pathway ablation in abdominal visceral heterotaxy with azygos continuation
Hongde Hu and others
EP Europace, Volume 18, Issue 1, January 2016, Page 56, https://doi.org/10.1093/europace/euv035
Clinical Research
Atrial fibrillation
Emerging risk factors and the dose–response relationship between physical activity and lone atrial fibrillation: a prospective case–control study
Naiara Calvo and others
EP Europace, Volume 18, Issue 1, January 2016, Pages 57–63, https://doi.org/10.1093/europace/euv216
Intrathoracic pressure swings induced by simulated obstructive sleep apnoea promote arrhythmias in paroxysmal atrial fibrillation
Christian Schlatzer and others
EP Europace, Volume 18, Issue 1, January 2016, Pages 64–70, https://doi.org/10.1093/europace/euv122
Ablation for atrial fibrillation
Electrophysiological findings following pulmonary vein isolation using radiofrequency catheter guided by contact-force and second-generation cryoballoon: lessons from repeat ablation procedures
Giuseppe Ciconte and others
EP Europace, Volume 18, Issue 1, January 2016, Pages 71–77, https://doi.org/10.1093/europace/euv224
Safety profile of multielectrode-phased radiofrequency pulmonary vein ablation catheter and irrigated radiofrequency catheter
K. Wasmer and others
EP Europace, Volume 18, Issue 1, January 2016, Pages 78–84, https://doi.org/10.1093/europace/euv046
One-year follow-up after irrigated multi-electrode radiofrequency ablation of persistent atrial fibrillation
Nikola Pavlović and others
EP Europace, Volume 18, Issue 1, January 2016, Pages 85–91, https://doi.org/10.1093/europace/euv020
Catheter ablation restores decreased plasma miR-409-3p and miR-432 in atrial fibrillation patients
Tian Liu and others
EP Europace, Volume 18, Issue 1, January 2016, Pages 92–99, https://doi.org/10.1093/europace/euu366
Pacing and Resynchronization Therapy
Optimal pacing sites for cardiac resynchronization therapy for patients with a systemic right ventricle with or without a rudimentary left ventricle
Aya Miyazaki and others
EP Europace, Volume 18, Issue 1, January 2016, Pages 100–112, https://doi.org/10.1093/europace/euu401
Cardiac electrophysiology
Radiofrequency ablation of the interventricular septum to treat outflow tract gradients in hypertrophic obstructive cardiomyopathy: a novel use of CARTOSound® technology to guide ablation
Robert M. Cooper and others
EP Europace, Volume 18, Issue 1, January 2016, Pages 113–120, https://doi.org/10.1093/europace/euv302
Radiation risk reduction in cardiac electrophysiology through use of a gridless imaging technique
Ian R. Smith and others
EP Europace, Volume 18, Issue 1, January 2016, Pages 121–130, https://doi.org/10.1093/europace/euv009
CASE EXPRESS REPORTS
Successful transvenous lead extraction after a failed open surgical attempt
Hanney Gonna and others
EP Europace, Volume 18, Issue 1, January 2016, Page 130, https://doi.org/10.1093/europace/euv290
Clinical Research
Cardiac electrophysiology
Permanent pacing after transcatheter aortic valve implantation of a CoreValve prosthesis as determined by electrocardiographic and electrophysiological predictors: a single-centre experience
Anna Kostopoulou and others
EP Europace, Volume 18, Issue 1, January 2016, Pages 131–137, https://doi.org/10.1093/europace/euv137
Electrocardiology and Risk Stratification
Beat-to-beat T-wave amplitude variability in the risk stratification of right ventricular outflow tract-premature ventricular complex patients
Tomohide Ichikawa and others
EP Europace, Volume 18, Issue 1, January 2016, Pages 138–145, https://doi.org/10.1093/europace/euu404
EP WIRE
The use of wearable cardioverter-defibrillators in Europe: results of the European Heart Rhythm Association survey
Radosław Lenarczyk and others
EP Europace, Volume 18, Issue 1, January 2016, Pages 146–150, https://doi.org/10.1093/europace/euw003
EHRA SURVEY
Patients’ attitude and knowledge about oral anticoagulation therapy: results of a self-assessment survey in patients with atrial fibrillation conducted by the European Heart Rhythm Association
Walid Amara and others
EP Europace, Volume 18, Issue 1, January 2016, Pages 151–155, https://doi.org/10.1093/europace/euv317
Letters to the Editor
Independent data about the safety and efficacy of rivaroxaban for prevention of stroke/embolism are needed
Claudia Stöllberger and others
EP Europace, Volume 18, Issue 1, January 2016, Page 156, https://doi.org/10.1093/europace/euv277
Independent data about the safety and efficacy of rivaroxaban for prevention of stroke/embolism are needed: Author reply
Jan Beyer-Westendorf
EP Europace, Volume 18, Issue 1, January 2016, Pages 156–158, https://doi.org/10.1093/europace/euv286
Advertisement intended for healthcare professionals
Advertisement intended for healthcare professionals